Skip to contentClarengateINTELLIGENCE
Companies/04569106

Lumora Limited

Research and experimental development on biotechnology · Uxbridge

ActiveUnited KingdomIncorporated 2002Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-03-31

IXBRL · 227 source facts · 29 selected values

Validation findings
XBRL valid
Reporting period
2024-04-01 to 2025-03-31
Extraction status
complete
Numeric facts
170
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2024-01-01.xsd
Currency
GBP
Source identifier
Prod224_2512_04569106_20250331
Source archive
Accounts_Monthly_Data-December2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2024-03-31

IXBRL · 335 source facts · 31 selected values

Not assessed
legacy record
Reporting period
2023-01-01 to 2024-03-31
Extraction status
Legacy / not assessed
Numeric facts
236
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_3200_04569106_20240331
Source archive
Accounts_Monthly_Data-December2024.zip

Registered details

04569106
Status
Active
Type
Private Limited Company
Incorporated
2002-10-22
Jurisdiction
—
Registered office
9, PARK PLACE, NEWDIGATE ROAD, UXBRIDGE, UB9 6EJ, UNITED KINGDOM

Classification

1 SIC codes
72110

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

2 matched grants
Novel strategies for single step molecular diagnostics assays with full dynamic range quantitation
BBSRC · Research Grant · 2014-05-31 – 2017-11-30 · with 2 other participants
£393,245
whole project
Single-step device and method for extraction of nucleic acids from clinical samples for molecular diagnostic tests at point-of-careLead
Innovate UK · Feasibility Studies · 2010-08-01 – 2011-07-31
£107,250
awarded